Colorcon announced that it will cooperate with BASF to add Kollicoat IR immediate-release coating polymer to Colorcon's film-coating portfolio.
Colorcon announced on Oct. 8, 2014, that it will cooperate with BASF to use Kollicoat IR for Colocon’s portfolio of ready-to-use coatings. Colorcon’s current film-coating options can be formulated for application and regulatory requirements, including immediate, sustained, and enteric release products. With the addition of Kollicoat IR to Colorcon’s portfolio, they will be able to use the immediate-release coating polymer.
Kollicoat IR is a polyvinyl alcohol-polyethylene glycol graft copolymer that is freely soluble in water. It can be processed at low temperatures with high-solids content.
“Kollicoat IR provides Colorcon with the capability to further expand our film coating portfolio, bringing more choice to our customers while providing customized solutions. We are pleased to cooperate with BASF to bring Kollicoat IR to a wider market, combining BASF’s polymer expertise with Colorcon’s knowledge of formulated film coating systems and our global reach,” said Cornelis van den Muyzenberg, vice-president of Sales and Business Development at Colorcon, in a press release.
Colorcon will use Kollicoat IR as an alternative for use in their Opadry systems, which are customizable, one-step film coating products that use polymer, plasticizer, and pigment in a dry concentrate.
Source: BASF
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.